EXIMIAS PHARMACEUTICAL CORPORATION
Eximias Pharmaceutical Corporation is a healthcare and pharmaceutical company. It focuses on the acquisition, development, and commercialization of unique oncology and infectious disease products. The company has three novel, late-stage products, THYMITAQ(R) and ORATAQ(TM) for oncology, and MACROTAC(TM) for oncology and infectious disease. THYMITAQ(R), the company's flagship product, is being evaluated in a Phase III ETHECC(C) trial for the treatment of patients with unresectable liver cancer. Eximias Pharmaceutical Corporation was founded in 1997. The company was founded by YM BioSciences on April 1, 2006.
EXIMIAS PHARMACEUTICAL CORPORATION
Industry:
Biotechnology Health Care Medical
Founded:
1997-01-01
Address:
Berwyn, Pennsylvania, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
0
Current Employees Featured
Investors List
Birchmere Ventures
Birchmere Ventures investment in Seed Round - Eximias Pharmaceutical Corporation
More informations about "Eximias Pharmaceutical Corporation"
YM BioSciences Completes Acquisition Of EXIMIAS Pharmaceutical …
May 10, 2006 Eximias will become a wholly-owned subsidiary of YM named YM BioSciences USA and will serve as the Company’s base of operations in the United States. Ms. Gail …See details»
Eximias Pharmaceutical Corp - Company Profile and News
Company profile page for Eximias Pharmaceutical Corp including stock price, company news, executives, board members, and contact informationSee details»
Eximias Pharmaceutical - Company Profile - Tracxn
Jul 20, 2024 Eximias Pharmaceutical (formerly called Zarix) was a late-stage company focussed on the acquisition, development and commercialization of unique oncology and infectious …See details»
Eximias Pharmaceutical Corporation acquired by YM BioSciences
Apr 1, 2006 Eximias Pharmaceutical Corporation Eximias Pharmaceutical Corporation is a Health Care company. Acquiring Organization: YM BioSciences YM BioSciences is a life …See details»
EXIMIAS Pharmaceutical Corporation - VentureRadar
EXIMIAS Pharmaceutical Corporation VentureRadar profile. Find out more about EXIMIAS Pharmaceutical Corporation including the VentureRadar Innovation and Growth scores, …See details»
YM BioSciences To Acquire EXIMIAS Pharmaceutical Corporation
Apr 14, 2006 CONTACT: David Allan, CEO, YM BioSciences Inc., Tel: (905) 629-9761; GailSchulze, President and CEO, Eximias Pharmaceutical Corporation, Tel: (610)560-0665See details»
Eximias Pharmaceutical Corporation - Funding, Financials, …
Apr 1, 2004 Eximias Pharmaceutical Corporation has raised 1 round. This was a Seed round raised on Apr 1, 2004 . Eximias Pharmaceutical Corporation is funded by Birchmere Ventures .See details»
Eximias Pharmaceutical Corp. - BioCentury Company Profiles - BCIQ
Oct 1, 2007 Eximias Pharmaceutical Corp. - BioCentury Company Profiles for the biopharma industrySee details»
The Miracle Hunter How Elizabeth Corsi turned a drug nobody …
Feb 1, 2004 Elizabeth Corsi, 49, is an accomplished veteran of the pharmaceutical industry who left the lush corporate life five years ago to run a pinch-penny startup called Eximias …See details»
EXIMIAS Pharmaceutical - Products, Competitors, Financials, …
EXIMIAS Pharmaceutical is a Berwyn, Pennsylvania-based Healthcare company. Use the CB Insights Platform to explore EXIMIAS Pharmaceutical's full profile. EXIMIAS Pharmaceutical - …See details»
Elizabeth Corsi – Eximias Pharmaceutical Corporation
Oct 14, 2002 ELIZABETH A. CORSI, President, Chief Executive Officer and Director of EXIMIAS Pharmaceutical Corporation, has spent over 17 years in multinational …See details»
Articles about EXIMIAS Pharmaceutical Corporation - BioSpace
Apr 14, 2006 1055 Westlakes Drive, Suite 200 Berwyn Pennsylvania 19312 United States Tel: 610-560-0600 Fax: 610-560-0700 Website: http://www.eximiaspharm.com/See details»
EXIMIAS Pharmaceutical Stock Price, Funding, Valuation, Revenue ...
See EXIMIAS Pharmaceutical funding rounds, investors, investments, exits and more. Evaluate their financials based on EXIMIAS Pharmaceutical's post-money valuation and revenue.See details»
Virginia SCC - Office of the Clerk - Business Lookup via Clerk's ...
Clerk's Information System. The Clerk's Information System (CIS) contains information on file in the Clerk’s Office for Virginia and foreign corporations, limited liability companies, general and …See details»
LABORATORY CORPORATION OF AMERICA NPI 1205272622 …
May 13, 2013 NPI Profile for Laboratory Corporation Of America in 2022 Opitz Blvd Woodbridge, Va 22191. Phone: (703) 707-2262 . Taxonomy 291U00000X Accepts: Blue Cross and Blue …See details»
Eximias Pharmaceutical Corporation - Updates, News, Events, …
Apr 1, 2006 Eximias Pharmaceutical Corporation is a Health Care company.See details»
Kaiser Permanente Caton Hill Pharmacy in Woodbridge - NPI No.
Kaiser Permanente Caton Hill Pharmacy (KAISER FOUNDATION HEALTH PLAN OF THE MID-ATLANTIC STATES, INC.) is a Managed Care Organization Pharmacy in Woodbridge, …See details»
Home | GSK US
GSK US is a leading biopharmaceutical company focusing on vaccines, specialty medicines, and respiratory care.See details»
Brockton Man Convicted of Defrauding Pharmaceutical Company …
1 day ago BOSTON — The boyfriend of a senior level employee in the technology operations group at the multinational pharmaceutical company Takeda Pharmaceutical Company Limited …See details»
Eximias Pharmaceutical Corporation - Contacts, Employees, Board …
Eximias Pharmaceutical Corporation has 1 current employee profile, Member Of The Board Of Directors Alan Y. Kwan. Alan Y. Kwan Member Of The Board Of Directors Unlock even more …See details»